scorecardresearch
Add as a preferred source on Google
Saturday, January 31, 2026
TopicVaccine authorisation

Topic: Vaccine authorisation

SII to manufacture India’s first qHPV vaccine against cervical cancer after DCGI approval

Cervical cancer in India is the 2nd most frequent cancer among women between 15-44 years of age. Currently, India is fully dependent on foreign manufacturers for the vaccine.

Why you won’t get Covishield, Covaxin at a chemist yet, despite full market approval

Covishield and Covaxin have been fully authorised only for use in adults, and can only be used in a ‘programmatic setting’, which means you’ll still have to register on CoWin.

Novavax’s Covid vaccine, made by Serum Institute of India, gets emergency use nod in Indonesia

Serum Institute of India, world's largest vaccine manufacturer, will market the nanoparticle protein-based vaccine in Indonesia under the brand name Covovax.

On Camera

What the last decade reveals about India’s economic path

In India, there has been remarkable certainty on taxes, particularly as the government has largely focused on slashing taxes, both direct and indirect, rather than increasing them.

Market Swings in India Surge From Historic Low as Budget Nears

New Delhi: Indian stocks are seeing a resurgence of volatility just weeks after being dubbed the world’s calmest equity market, with growing skepticism sparking...

During Op Sindoor, hackers targeted NSE website 40 crore times in 10 minutes, Exchange CEO says

NSE CEO Ashishkumar Chauhan was speaking at Off The Cuff event hosted by ThePrint's Editor-in-Chief Shekhar Gupta. He said that NSE, on average, sees 20 crore cyberattacks each day.

Swiss report should now close Op Sindoor debate. Knowing when to stop the fight is key too

The key to fighting a war successfully, or even launching it, is a clear objective. That’s an entirely political call. It isn’t emotional or purely military.